Dabigatran Etexilate 00904-7253-04
- Manufacturer
- Major Pharmaceuticals
- Dosage Form
- Capsule, Coated Pellets
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 23, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA208040
Need to source Dabigatran Etexilate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dabigatran Etexilate Mesylate | 75 mg/1 |
Drug Class
Direct Thrombin Inhibitor [EPC]Thrombin Inhibitors [MoA]
Selected Package
00904-7253-04Selected3 BLISTER PACK in 1 CARTON (0904-7253-04) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0904-7253-35)
Other packages for this product(1)
6 BLISTER PACK in 1 CARTON (0904-7253-68) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0904-7253-35)